Alan Chiang

Alan Chiang has a strong background in biometrics and statistics, with notable work experience at various companies. Alan is currently serving as the Head of Biometrics at Lyell Immunopharma, where they oversee biostatistics, data management, and statistical programming for the company's portfolio. Alan's responsibilities include the design, delivery, and interpretation of clinical trials.

Prior to their current role, Alan worked as the Executive Director of Biostatistics at Bristol Myers Squibb from 2019 to 2022. Before that, they held the position of Senior Research Advisor in Statistics at Eli Lilly and Company from 2002 to 2019, where they provided valuable insights and expertise in the field.

Alan's career in biometrics and statistics began at Nielsen, where they worked as a Market Researcher from 1999 to 2002. Overall, Alan has a comprehensive and diverse work experience in the field, making him a highly qualified professional in the biometrics industry.

Alan Chiang earned their PhD in Statistics from the University of Wisconsin-Madison, where they studied from 1994 to 1999.